BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10329694)

  • 1. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2.
    Sahni A; Sporn LA; Francis CW
    J Biol Chem; 1999 May; 274(21):14936-41. PubMed ID: 10329694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.
    Sahni A; Francis CW
    Blood; 2000 Dec; 96(12):3772-8. PubMed ID: 11090059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2.
    Sahni A; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1271-7. PubMed ID: 12871330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth.
    Sahni A; Altland OD; Francis CW
    J Thromb Haemost; 2003 Jun; 1(6):1304-10. PubMed ID: 12871334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3.
    Sahni A; Francis CW
    Blood; 2004 Dec; 104(12):3635-41. PubMed ID: 15297314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form.
    Sahni A; Guo M; Sahni SK; Francis CW
    Blood; 2004 Jul; 104(2):409-14. PubMed ID: 15039285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells.
    Sahni A; Sahni SK; Simpson-Haidaris PJ; Francis CW
    J Thromb Haemost; 2004 Sep; 2(9):1629-36. PubMed ID: 15333041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation.
    Sahni A; Baker CA; Sporn LA; Francis CW
    Thromb Haemost; 2000 May; 83(5):736-41. PubMed ID: 10823272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.
    Sahni A; Khorana AA; Baggs RB; Peng H; Francis CW
    Blood; 2006 Jan; 107(1):126-31. PubMed ID: 16160009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of basic fibroblast growth factor to fibrinogen and fibrin.
    Sahni A; Odrljin T; Francis CW
    J Biol Chem; 1998 Mar; 273(13):7554-9. PubMed ID: 9516457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a binding site on human FGF-2 for fibrinogen.
    Peng H; Sahni A; Fay P; Bellum S; Prudovsky I; Maciag T; Francis CW
    Blood; 2004 Mar; 103(6):2114-20. PubMed ID: 14630795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells.
    Gu X; Seong GJ; Lee YG; Kay EP
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2326-34. PubMed ID: 8843917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF).
    Pintucci G; Froum S; Pinnell J; Mignatti P; Rafii S; Green D
    Thromb Haemost; 2002 Nov; 88(5):834-42. PubMed ID: 12428103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions.
    Kang SS; Gosselin C; Ren D; Greisler HP
    Surgery; 1995 Aug; 118(2):280-6; discussion 286-7. PubMed ID: 7638745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin glue containing fibroblast growth factor type 1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model.
    Zarge JI; Huang P; Husak V; Kim DU; Haudenschild CC; Nord RM; Greisler HP
    J Vasc Surg; 1997 May; 25(5):840-8; discussion 848-9. PubMed ID: 9152311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue.
    Shireman PK; Xue L; Maddox E; Burgess WH; Greisler HP
    J Vasc Surg; 2000 Feb; 31(2):382-90. PubMed ID: 10664506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways.
    Kroon ME; Koolwijk P; van der Vecht B; van Hinsbergh VW
    J Cell Sci; 2001 Feb; 114(Pt 4):825-33. PubMed ID: 11171387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue.
    Erzurum VZ; Bian JF; Husak VA; Ellinger J; Xue L; Burgess WH; Greisler HP
    J Vasc Surg; 2003 May; 37(5):1075-81. PubMed ID: 12756357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
    Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.